Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | CYP2A6 | P11509 | 3/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.64 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | MAOA | P21397 | 2/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | KCNA2 | P16389 | 2/20 | 0.64 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | PGR | P06401 | 1/20 | 0.64 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | ACHE | P22303 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bergaptol SCHEMBL31097369 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP3A4CYP2A6L3MBTL1MAPT | |
| SCHEMBL4421214 | 0.82 | CYP3A4 (0.68) | ALDH1A1CYP3A4CYP2A6L3MBTL1MAPT | |
| SCHEMBL6802035 | 0.82 | ALDH1A1 (0.70) | ALDH1A1CYP3A4CYP2A6L3MBTL1MAPT | |
| SCHEMBL22361197 | 0.79 | ALDH1A1 (0.66) | ALDH1A1CYP3A4CYP2A6L3MBTL1MAPT | |
| Bergapten SCHEMBL50066 | 0.78 | ALDH1A1 (1.00) | ALDH1A1CYP3A4CYP2A6L3MBTL1MAPT | |
| Bergapten SCHEMBL4731782 | 0.78 | ALDH1A1 (1.00) | ALDH1A1CYP3A4CYP2A6L3MBTL1MAPT | |
| Bergapten SCHEMBL29529284 | 0.78 | ALDH1A1 (1.00) | ALDH1A1CYP3A4CYP2A6L3MBTL1MAPT | |
| SCHEMBL20036256 | 0.78 | ALDH1A1 (0.64) | ALDH1A1CYP3A4CYP2A6L3MBTL1MAPT | |
| SCHEMBL19346062 | 0.78 | ALDH1A1 (0.72) | ALDH1A1CYP3A4CYP2A6L3MBTL1MAPT | |
| SCHEMBL6991733 | 0.78 | ALDH1A1 (0.64) | ALDH1A1CYP3A4CYP2A6L3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024134655-A1 | CITRUS PLANTS WITH MODIFIED PRODUCTION OF COUMARINS AND FURANOCOUMARINS METHODS OF PRODUCING SAME AND PRODUCTS OBTAINED THEREBY | THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI INSTITUTE) (IL) | 2024-06-27 | — | — | WO | claimed |
| EP-3223796-B1 | PHARMACEUTICAL COMPOSITIONS, PREPARATION AND USES THEREOF | CURADIGM SAS (FR) | 2021-07-21 | — | — | EP | claimed |
| CN-102234578-A | Preparation method of fingered citron-osmanthus essence | DEBIN XU | 2011-11-09 | — | — | CN | claimed |
| US-8026285-B2 | Control release of biologically active compounds from multi-armed oligomers | BEZWADA BIOMEDICAL, LLC (US) | 2011-09-27 | — | — | US | claimed |
| CN-101851557-A | Preparation method for fingered citron osmanthus fragrance | DEBIN XU | 2010-10-06 | — | — | CN | claimed |
| US-20090170927-A1 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2009-07-02 | — | — | US | claimed |
| US-20090155224-A1 | Dimethyl amino ethyl ether psoralens and methods for their production and use | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2009-06-18 | — | — | US | claimed |
| US-20090076174-A1 | CONTROL RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | BEZWADA BIOMEDICAL, LLC (US) | 2009-03-19 | — | — | US | claimed |
| CN-101384241-A | Vitamin C transporter production promoter | FANCL CORP (JP) | 2009-03-11 | — | — | CN | claimed |
| EP-1951260-A2 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND ABSORBABLE THEREFROM | Bezwada Biomedical LLC (US) | 2008-08-06 | — | — | EP | claimed |
| WO-2007053794-A2 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND ABSORBABLE THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2007-05-10 | — | — | WO | claimed |
| US-7098244-B2 | Antibacterial agent | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-08-29 | — | — | US | claimed |
| WO-2004037827-A1 | SYNTHESIS OF SPIRO ORTHO ESTERS, SPIRO ORTHO CARBONATES, AND INTERMEDIATES | BIOAVAILABILITY SYSTEMS, LLC (US) | 2004-05-06 | — | — | WO | claimed |
| US-20040002611-A1 | Synthesis of spiro esters, spiro ortho carbonates, and intermediates | BIOAVAILABILITY SYSTEMS, LLC (US) | 2004-01-01 | — | — | US | claimed |
| US-6613918-B1 | Reacting an ester or carbonate with a tri C1-20 alkyl oxonium hexafluorophosphate; Bergaptols | BIOAVAILABILITY SYSTEMS, LLC | 2003-09-02 | — | — | US | claimed |
| WO-2026104851-A1 | PHARMACEUTICAL COMPOSITIONS | Apollo AP10 Limited (GB) | 2026-05-21 | — | — | WO | disclosed |
| US-20260060966-A1 | METHOD OF PREVENTING OR TREATING HEART FAILURE IN A PATIENT USING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE | BAYER AG (DE) | 2026-03-05 | — | — | US | disclosed |
| US-4429138-A | MULTISTEP, FROM PHLOROGLUCINOL | GOUPIL JEAN JACQUES (FR) | 1984-01-31 | — | — | US | disclosed |
| US-4217445-A | SKIN DISORDERS | FOTOBIO HOLDING AG (CH) | 1980-08-12 | — | — | US | disclosed |
| US-4217445-A | SKIN DISORDERS | FOTOBIO HOLDING AG (CH) | 1980-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076174-A1 | CONTROL RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | MME, CTSA, ALG1 | ALDH1A1 1662/4885CYP3A4 2364/4885CYP2A6 2163/4885 |
| US-20260060966-A1 | METHOD OF PREVENTING OR TREATING HEART FAILURE IN A PATIENT USING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE | ALB, REN, TTR | ALDH1A1 732/4885CYP3A4 924/4885CYP2A6 1435/4885 |
| US-20090170927-A1 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM | COMT, AOX1, UGT1A6 | ALDH1A1 384/4885CYP3A4 345/4885CYP2A6 132/4885 |
| US-20040002611-A1 | Synthesis of spiro esters, spiro ortho carbonates, and intermediates | SYMPK, OXSR1, OSBP | ALDH1A1 3184/4885CYP3A4 170/4885CYP2A6 741/4885 |
| US-20090155224-A1 | Dimethyl amino ethyl ether psoralens and methods for their production and use | HLA-C, HLA-A, HLA-B | ALDH1A1 2269/4885CYP3A4 677/4885CYP2A6 1312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.